There are all kinds of reports these days surrounding the covid vaccines and especially their potential side effects. AstraZeneca is making headlines these days due to various reasons.
One of them was the fact that ABC.net.au just noted that the AstraZeneca vaccine will now be called Vaxzevria after an application to rename it was approved by Australia’s medical regulator.
It’s been also reported that the company asked the Therapeutic Goods Administration (TGA) to approve the rebrand – it said that it would bring the name into line with what the vaccine is called in European countries and Canada.
According to the reports, the TGA said it hoped the change in name would make sure there would be no confusion in the future.
“This is expected to alleviate confusion and further clarify that the vaccine produced by CSL and Seqirus in Melbourne is the same as that produced internationally,” the statement said.
The same statement continued and explained the following:
“This name change will also help facilitate international recognition for Australians who have been vaccinated with the AstraZeneca vaccine.”
AstraZeneca’s antibody therapy
Reuters press agency just revealed that AstraZeneca said on Friday its antibody therapy met the main goal of preventing COVID-19 disease in a late-stage study.
All this managed to put the British drugmaker on track to potentially offer an alternative to vaccines for people with weakened immune systems.
US experts recommend vaccine boosters
It’s been just revealed by the latest reports that the US experts are expected to recommend Covid 19 vaccine boosters for all Americans.
Yahoo News notes that this will be happening for everyone, regardless of age, eight months after they received their second dose of the shot. This way, people will ensure lasting protection against the coronavirus as the delta variant spreads across the country.
Stay tuned for more corona-related news, and make sure to remain safe, you and your loved ones.